Sign in

CIK 0001479419

  • Non-accelerated filer
  • Smaller reporting company

KALA BIO, Inc.

Sign in to watch
Ticker
KALA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
270604595
Phone
+1 781-996-5252
Business address
1167 MASSACHUSETTS AVENUE, ARLINGTON, MA, 02476
Former names
KALA BIO, Inc., Kala Pharmaceuticals, Inc.
  1. 4 Exercise or conversion Trachtenberg Eric acquired 28,901 shares (option exercise)
  2. 4 Exercise or conversion Chief Financial Officer acquired 43,477 shares (option exercise)
  3. 4 Exercise or conversion Chief Medical Officer acquired 67,771 shares (option exercise)
  4. 4 Exercise or conversion Chief Scientific Officer acquired 31,000 shares (option exercise)
  5. 4 Open-market buy Chief Operating Officer bought 10,000 shares at $5.75 ($57,500)
  6. 4 Open-market buy Director bought 2,534,854 shares at $7.89 ($19,999,998)
  7. 4 Open-market buy Director bought 6,337,135 shares at $7.89 ($49,999,995)
  8. 4 Open-market buy Director bought 6,337,135 shares at $7.89 ($49,999,995)
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 10 of 15 · 288 filings